ATE246504T1 - Verwendung eines antimykotikum - Google Patents

Verwendung eines antimykotikum

Info

Publication number
ATE246504T1
ATE246504T1 AT96919769T AT96919769T ATE246504T1 AT E246504 T1 ATE246504 T1 AT E246504T1 AT 96919769 T AT96919769 T AT 96919769T AT 96919769 T AT96919769 T AT 96919769T AT E246504 T1 ATE246504 T1 AT E246504T1
Authority
AT
Austria
Prior art keywords
pct
date nov
azole
sec
inhibitor
Prior art date
Application number
AT96919769T
Other languages
English (en)
Inventor
Josef Gottfried Meingassner
Neil Stewart Ryder
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE246504T1 publication Critical patent/ATE246504T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
AT96919769T 1995-05-12 1996-05-10 Verwendung eines antimykotikum ATE246504T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination
PCT/EP1996/002022 WO1996035423A1 (en) 1995-05-12 1996-05-10 Antifungal composition

Publications (1)

Publication Number Publication Date
ATE246504T1 true ATE246504T1 (de) 2003-08-15

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919769T ATE246504T1 (de) 1995-05-12 1996-05-10 Verwendung eines antimykotikum

Country Status (25)

Country Link
US (1) US5985906A (de)
EP (1) EP0824350B1 (de)
JP (1) JPH11504931A (de)
KR (1) KR100443535B1 (de)
CN (1) CN1100539C (de)
AT (1) ATE246504T1 (de)
AU (1) AU712914B2 (de)
CA (1) CA2219651C (de)
CY (1) CY2496B1 (de)
CZ (1) CZ291144B6 (de)
DE (1) DE69629367T2 (de)
DK (1) DK0824350T3 (de)
ES (1) ES2205042T3 (de)
FI (1) FI120079B (de)
GB (1) GB9509631D0 (de)
HU (1) HU224920B1 (de)
IL (2) IL118219A (de)
MX (1) MX9708699A (de)
NO (1) NO317030B1 (de)
PL (1) PL322749A1 (de)
PT (1) PT824350E (de)
SK (1) SK150797A3 (de)
TW (1) TW464492B (de)
WO (1) WO1996035423A1 (de)
ZA (1) ZA963754B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
IL147803A0 (en) * 1999-08-24 2002-08-14 Ariad Gene Therapeutics Inc 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
RU2200003C1 (ru) * 2001-11-08 2003-03-10 Нижегородский химико-фармацевтический завод (ОАО "НИЖФАРМ") Твердая лекарственная форма тербинафина гидрохлорида
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
JP2007513199A (ja) 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
SI1867332T1 (sl) 2005-04-07 2011-11-30 Toyama Chemical Co Ltd Farmacevtska sestava in postopek z rabo v kombinaciji s protiglivičnim sredstvom
JP5132569B2 (ja) 2006-10-06 2013-01-30 富山化学工業株式会社 フェニルアミジン誘導体を含有する医薬組成物および抗真菌剤を組み合わせて使用する方法
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
EP2245165A4 (de) 2008-01-11 2011-06-01 Massachusetts Eye & Ear Infirm Transgene konditionalstopp-dimerisierbare-caspase-tiere
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
ES2205042T3 (es) 2004-05-01
ZA963754B (en) 1997-11-10
CZ291144B6 (cs) 2002-12-11
HK1016064A1 (en) 1999-10-29
KR100443535B1 (ko) 2004-12-17
CN1184427A (zh) 1998-06-10
SK150797A3 (en) 1998-05-06
CA2219651C (en) 2007-03-27
IL118219A (en) 2001-08-26
NO975134D0 (no) 1997-11-07
PL322749A1 (en) 1998-02-16
HUP9801140A2 (hu) 1999-01-28
FI973812A0 (fi) 1997-09-26
DE69629367T2 (de) 2004-06-09
CA2219651A1 (en) 1996-11-14
PT824350E (pt) 2003-12-31
EP0824350B1 (de) 2003-08-06
WO1996035423A1 (en) 1996-11-14
AU712914B2 (en) 1999-11-18
DE69629367D1 (de) 2003-09-11
MX9708699A (es) 1998-02-28
DK0824350T3 (da) 2003-11-03
KR19990014708A (ko) 1999-02-25
FI120079B (fi) 2009-06-30
CY2496B1 (en) 2005-09-02
IL118219A0 (en) 1996-09-12
NO975134L (no) 1997-11-07
FI973812L (fi) 1997-11-11
NO317030B1 (no) 2004-07-26
CN1100539C (zh) 2003-02-05
HU224920B1 (en) 2006-04-28
GB9509631D0 (en) 1995-07-05
JPH11504931A (ja) 1999-05-11
US5985906A (en) 1999-11-16
EP0824350A1 (de) 1998-02-25
HUP9801140A3 (en) 2000-07-28
CZ354797A3 (cs) 1998-02-18
TW464492B (en) 2001-11-21
AU5818396A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
FI973812A0 (fi) Antifungaalisia koostumuksia
NO975716L (no) Imidazolforbindelser
ATE373655T1 (de) 1-(heteroaryl-phenyl)-kondensierte pyrazol- derivate als factor xa inhibitoren
ATE307804T1 (de) Effiziente durch liganden vermittelte ullmann kupplung von anilinen und azolen
ATE184577T1 (de) Verfahren zur reversiblen speicherung von wasserstoff
BR0114054A (pt) Método para tratar alergias usando pirazóis substituìdos
AP9701018A0 (en) Squalene synthetase inhibitor compounds.
ATE218954T1 (de) Holzschutzmittel für den nachschutz
ITBO970019A0 (it) Macchina e metodo per la composizione di mazzette di foglietti, in par ticolare banconote.
FI941772A7 (fi) Paperinliimausmenetelmä ja siihen soveltuva koostumus
ATE207295T1 (de) Fungizide mischungen
NO20041950L (no) Fremgangsmate og anordning for prosessering av post
SE9600760L (sv) Sätt att sterilisera slutna förpackningar
ATE196823T1 (de) Algizidkombination
DE60119742D1 (de) Methode zur behandlung der hyperaktiven blase
ATE361898T1 (de) Verwendung von ozonierten lösungen von tetrasilber tetraoxide
DE69418689D1 (de) Nitrone verwendbar zum abfangen von freien radikalen
EP0566666A4 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
NO975084L (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
ZA966772B (en) 1-[2-(2,3-dihydro-1H-inden-1-yl)ethyl]-4-(naphth-1-yl) piperazine derivatives, their preparation and their application in therapeutics.
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
UA42111C2 (uk) Засіб для прихованого маркування небіологічних об'єктів
TH28830B (th) องค์ประกอบซึ่งมีฤทธิ์ต่อต้านฟังไจ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824350

Country of ref document: EP

REN Ceased due to non-payment of the annual fee